Trials / Active Not Recruiting
Active Not RecruitingNCT04734145
Using e-Nose Technology to Identify Early Lung Cancer
Breathprinting (e-Nose) Technology for the Identification of Early-Stage Lung Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the ability of a new technology called breathprinting, or electronic nose (e-nose), to detect early-stage lung cancer. Additionally, researchers also want to see if the e-nose technology is more effective at diagnosing lung cancer if the tumor size is larger.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Breathprinting test | Consented, enrolled participants will undergo a breathprinting test (e-nose) during the presurgical visit and at the same facility as their presurgical or prebiopsy visit, before any attempt is made to obtain cytohistological diagnosis of the pulmonary nodule. |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2026-01-25
- Completion
- 2026-01-25
- First posted
- 2021-02-02
- Last updated
- 2025-05-16
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04734145. Inclusion in this directory is not an endorsement.